CME Group Inc. cash flow to debt ratio of 113.84% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

CME Group Inc.'s free cash flow has increased 16.60% from $3.60B last year to $4.19B, signaling increasing performance

CME Group Inc.'s debt to equity ratio is 0.13, which means that the company's assets are healthy financed, signaling financial stability.

CME Group Inc.'s debt has increased relative to shareholder equity from 0.13 last year to 0.13 today, signaling weakened financials

CME Group Inc. has a net cash position, so leverage is healthy.

CME Group Inc.'s interest coverage ratio of 50.27 indicates that earnings with good margin can cover interest payments on company debt

CME Group Inc.'s profit margin has increased (9.67%) in the last year from 57.52% to 63.08%, signaling increasing performance

CME Group Inc.'s short-term assets of $5.19B exceed its short-term liabilities of $55.80M

CME Group Inc.'s return on assets of 2.19% is lower than the 5.00% threshold, indicating inefficient asset utilization

CME Group Inc.'s return on equity of 15.53%, is higher than 15.00%, indicating good performance

CME Group Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

CME Group Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings

CME Group Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

CME Group Inc. has a free cash flow yield of 4.42%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

CME Group Inc.'s yearly earnings has increased 14.71% since last year from $3.53B to $4.04B, signaling increasing performance

CME Group Inc.'s yearly revenue has increased 6.37% since last year from $6.13B to $6.52B, signaling increasing performance

ROIC 9.38% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

CME Group Inc.'s 3-year revenue CAGR of 9.11% is positive, indicating growing revenue over the past 3 years

CME Group Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

CME Group Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

CME Group Inc. is overvalued relative to its fair value price of 207.01 based on Discounted Cash Flow model

CME Group Inc. has an earnings yield of 4.50%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

CME Group Inc. is overvalued relative to its fair value price of 112.21 based on EBITDA multiple model

CME Group Inc. has an EV/EBITDA ratio of 16.43x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

CME Group Inc. is overvalued relative to its fair value price of 166.06 based on Earnings Fair Value model

CME Group Inc. has a PEG-ratio over 1 which is considered overvalued

CME Group Inc. has a price-to-book ratio of 3.59x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

CME Group Inc. has a price-to-sales ratio of 14.01x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue